Chiang-Yun Chen | Researcher
CHO PHARMA INC.

Chaing-Yun Chen, Ph.D., is a researcher at CHO PHARMA in Taiwan, where he specialize in a range of activities within pharmaceutical development, particularly focused on carbohydrate-based vaccine development. With a Ph.D. in Chemistry and a comprehensive background in both preclinical and clinical research, Dr. Chen contributes to the advancement of IND enabling, manufacturing, and pharmacology studies.
At CHO PHARMA, Dr. Chen has been involved in Phase I IND enabling for vaccines against Klebsiella Pneumoniae, overseeing critical tasks such as CTD documentation, and IND submission. In addition, Dr. Chen plays an integral role in Chemical, Manufacturing, and Control (CMC) for vaccine product, focusing on process development, scale-up, technology transfer to CDMOs, on-site monitoring, and analytical method development/qualification.
A key part of Dr. Chen’s work involves coordinating pharmacology and toxicology evaluations, overseeing animal dose and challenge studies, and the development of functional assays to assess therapeutic efficacy and safety.